Victoria-Apotheke
⚠️ High Risk
FEI: 3000163767 • Zurich • SWITZERLAND
FEI Number
3000163767
Location
Zurich
Country
SWITZERLANDAddress
Bahnofstrasse 71, , Zurich, , Switzerland
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
DIRECTIONS
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.
AGR RX
The article appears to be a prescription drug manufactured in the U.S. and offered for import by other than the manufacturer and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 8/29/2014 | 65DCQ99OXYTOCIC N.E.C. | 75UNAPPROVED | Division of Northeast Imports (DNEI) |
| 9/19/2013 | 61HLF21CLOFAZIMINE (TUBERCULOSTATIC) (ANTI-BACTERIAL) | 75UNAPPROVED | Division of Northern Border Imports (DNBI) |
| 4/6/2012 | 62QCK99ANTI-RHEUMATIC N.E.C. | 75UNAPPROVED | New York District Office (NYK-DO) |
| 2/27/2012 | 65DCQ99OXYTOCIC N.E.C. | 75UNAPPROVED | New York District Office (NYK-DO) |
| 1/7/2011 | 66SCB03BETAHISTINE HCL (VASODILATOR) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 2/5/2009 | 65QCS06PRAZEPAM (RELAXANT) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 4/16/2008 | 66VCB99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New York District Office (NYK-DO) |
| 7/5/2007 | 62GIJ99ANTI-INFLAMMATORY N.E.C. | 118NOT LISTED | New York District Office (NYK-DO) |
| 3/12/2007 | 64EDA99ENZYME N.E.C. | 118NOT LISTED | New York District Office (NYK-DO) |
| 3/5/2007 | 64RDA99HORMONE N.E.C. | 118NOT LISTED | New York District Office (NYK-DO) |
| 12/4/2006 | 61HCB99ANTI-BACTERIAL, N.E.C. | 75UNAPPROVED | New York District Office (NYK-DO) |
| 10/31/2006 | 64EDA99ENZYME N.E.C. | New York District Office (NYK-DO) | |
| 10/27/2006 | 62HDA99ANTI-MICROBIAL N.E.C. | 75UNAPPROVED | New York District Office (NYK-DO) |
| 5/18/2006 | 64EDA99ENZYME N.E.C. | 16DIRECTIONS | New York District Office (NYK-DO) |
| 9/1/2005 | 66YDA99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C. | 75UNAPPROVED | New York District Office (NYK-DO) |
| 7/26/2005 | 65VCY13CLOZAPINE (SEDATIVE) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 7/22/2005 | 66VIP99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 4/15/2005 | 66VCF99MISCELLANEOUS PATENT MEDICINES, ETC. | New York District Office (NYK-DO) | |
| 3/22/2005 | 66VDA99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New York District Office (NYK-DO) |
| 3/9/2005 | 66VAY99MISCELLANEOUS PATENT MEDICINES, ETC. | New York District Office (NYK-DO) | |
| 3/9/2005 | 66VCA99MISCELLANEOUS PATENT MEDICINES, ETC. | New York District Office (NYK-DO) | |
| 12/28/2004 | 66VCE99MISCELLANEOUS PATENT MEDICINES, ETC. | New York District Office (NYK-DO) | |
| 12/13/2004 | 84MUZSTIMULATOR, VAGUS NERVE, IMPLANTED (DEPRESSION) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 12/9/2004 | 57CY02INFLUENZA VIRUS VACCINE | 118NOT LISTED | New York District Office (NYK-DO) |
| 11/22/2004 | 64MCP03GONADORELIN HCL (GONAD-STIMULATING PRINCIPLE) | New York District Office (NYK-DO) | |
| 11/22/2004 | 65MCP01PROTIRELIN (PROTHYROTROPIN) | New York District Office (NYK-DO) | |
| 10/22/2004 | 66VCA99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New York District Office (NYK-DO) |
| 7/30/2004 | 66VAA99MISCELLANEOUS PATENT MEDICINES, ETC. | New York District Office (NYK-DO) | |
| 7/30/2004 | 66VAA99MISCELLANEOUS PATENT MEDICINES, ETC. | New York District Office (NYK-DO) | |
| 7/30/2004 | 56YBB99ANTIBIOTIC N.E.C. | New York District Office (NYK-DO) | |
| 5/18/2004 | 61NCA99ANTI-DEPRESSANT N.E.C. | 75UNAPPROVED | New York District Office (NYK-DO) |
| 4/28/2004 | 66VCA99MISCELLANEOUS PATENT MEDICINES, ETC. | New York District Office (NYK-DO) | |
| 4/28/2004 | 66VCA99MISCELLANEOUS PATENT MEDICINES, ETC. | New York District Office (NYK-DO) | |
| 4/13/2004 | 65ACB99MEMORY ADJUVANT, N.E.C. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 2/27/2004 | 56YDB99ANTIBIOTIC N.E.C. | New York District Office (NYK-DO) | |
| 2/4/2004 | 65ADB03TACRINE HYDROCHLORIDE (MEMORY ADJUVANT) | 179AGR RX | New Orleans District Office (NOL-DO) |
| 8/5/2003 | 56YDC99ANTIBIOTIC N.E.C. | New York District Office (NYK-DO) | |
| 4/23/2003 | 66VAA99MISCELLANEOUS PATENT MEDICINES, ETC. | New York District Office (NYK-DO) | |
| 9/5/2002 | 66VCP99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 1/6/2002 | 66VAY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
Frequently Asked Questions
What is Victoria-Apotheke's FDA import refusal history?
Victoria-Apotheke (FEI: 3000163767) has 40 FDA import refusal record(s) in our database, spanning from 1/6/2002 to 8/29/2014.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Victoria-Apotheke's FEI number is 3000163767.
What types of violations has Victoria-Apotheke received?
Victoria-Apotheke has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Victoria-Apotheke come from?
All FDA import refusal data for Victoria-Apotheke is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.